Actively Recruiting
The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF
Led by University of Virginia · Updated on 2024-05-07
36
Participants Needed
1
Research Sites
174 weeks
Total Duration
On this page
Sponsors
U
University of Virginia
Lead Sponsor
G
Grain Foods Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is trying to find out how best to improve common measures of health and survival in those diagnosed with heart failure with preserved ejection fraction (HFpEF) through the implementation of 4 weeks of an exercise training program consisting of high intensity interval training, dietary approaches to stop hypertension (DASH diet), or a combination of the two. Currently there are not established guidelines that have been shown to improve clinical end points in those with this HFpEF.
CONDITIONS
Official Title
The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 40 years of age or older
- Diagnosed with heart failure with preserved ejection fraction
- Have New York Heart Association (NYHA) class II or III symptoms
- Have physician clearance for exercise training
- Have physician clearance to follow the DASH diet
- Complete COVID-19 vaccination status
You will not qualify if you...
- Have unstable angina
- Had a myocardial infarction in the past 4 weeks
- Have uncompensated heart failure
- Have New York Heart Association (NYHA) class IV symptoms
- Have complex ventricular arrhythmias
- Have musculoskeletal issues preventing stationary bicycling exercise
- Have symptomatic severe aortic stenosis
- Have acute pulmonary embolus
- Have acute myocarditis
- Have uncontrolled high blood pressure
- Are not compliant with medications
- Cannot follow the DASH diet
- Have food allergies to nuts or wheat
- Are pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Virginia University Hospital
Charlottesville, Virginia, United States, 22903
Actively Recruiting
Research Team
S
Siddhartha S Angadi, PhD
CONTACT
N
Nathan Weeldreyer, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here